Skip to content

US · ZCMD · MEDICAL - HEALTHCARE INFORMATION SERVICES

Zhongchao Inc. (ZCMD) intrinsic value and stock valuation

$0.78as of 2026-11-21 · Mkt cap 40.98K

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Zhongchao Inc. DCF and intrinsic value

InvestorsCraft values ZCMD with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from ZCMD’s statements →

Zhongchao Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Information Services Shanghai, SH 200040 izcmd.com

How the business is doing

Fiscal 2017–2025, USD

Revenue
$11.4M-8.8% 5y CAGRd
20172025
Net income
-$-6.31M
20172025
Free cash flow
$690K
20172025
Total equity
$22.6M-6.6% 5y CAGRd
20172025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2017–2025, USD
20252024202320222021
Revenue$11.4M$15.9M$19.4M$14.2M$16.3M
Operating income-$-6.19M-$-340K-$-13.28M-$-2.95M-$-320K
Net income-$-6.31M-$-640K-$-11.34M-$-2.94M$240K
EPSd-$-157.75M-$-64M———
Operating cash flow$850K-$-1.47M$50K-$-660K$2.86M
Capital expenditure-$-150K-$-3.05M-$-840K-$-1.86M-$-1.8M
Free cash flow$690K-$-4.52M-$-790K-$-2.52M$1.06M
Total assets$24.3M$25.9M$24.4M$38.6M$36.3M
Total debt$30K$60K$810K$1.7M$200K
Net debt-$-8.07M-$-7.78M-$-6.74M-$-9.82M-$-13.71M
Total equity$22.6M$24.2M$21M$33M$32.6M
Cash and short-term investments$13.9M$13.1M$13.5M$12M$14.2M
Income statement
20252024202320222021
Revenue$11.4M$15.9M$19.4M$14.2M$16.3M
Cost of revenue$6.54M$6.95M$10.9M$7.79M$6.86M
Gross profit$4.83M$8.91M$8.51M$6.36M$9.44M
Research and development expenses$10K$250K$510K$410K$760K
Selling, general and administrative expenses$11M$9M$13.4M$8.9M$9M
Other expenses$0.00$0.00$7.87M$0.00$0.00
Operating expenses$11M$9.25M$21.8M$9.31M$9.76M
Cost and expenses$17.6M$16.2M$32.7M$17.1M$16.6M
Interest income$340K$240K$240K$140K$180K
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$320K$430K$920K$730K$700K
Ebitda-$-5.45M$90K-$-4.49M-$-1.82M$590K
Operating income-$-6.19M-$-340K-$-13.28M-$-2.95M-$-320K
Total other income/expenses, net$420K$400K$1.31M$400K$210K
Income before tax-$-5.77M$60K-$-11.98M-$-2.55M-$-110K
Income tax expense$50K$340K-$-670K$270K-$-350K
Net income-$-6.31M-$-640K-$-11.34M-$-2.94M$240K
Weighted average shares outstanding$40K$10K$0.00$0.00$0.00
Weighted average diluted shares outstanding$40K$10K$0.00$0.00$0.00
Balance sheet
20252024202320222021
Cash and short-term investments$13.9M$13.1M$13.5M$12M$14.2M
Net receivables$2.88M$4.78M$3.02M$9.13M$12.4M
Inventory$0.00$590K$590K$190K$0.00
Total current assets$17M$18.7M$18.7M$22.7M$27.3M
Property, plant and equipment, net$5.9M$5.96M$4.02M$5.8M$4.31M
Goodwill and intangible assets$10K$10K$20K$6.98M$380K
Long-term investments$1.23M$1.09M$1.31M$1.26M$2.14M
Total non-current assets$7.35M$7.18M$5.71M$15.9M$9.01M
Total assets$24.3M$25.9M$24.4M$38.6M$36.3M
Accounts payable$530K$540K$680K$140K$40K
Short-term debt$30K$30K$240K$480K$90K
Deferred revenue$150K$200K$840K$400K$10K
Total current liabilities$1.53M$1.53M$2.68M$4.17M$3.59M
Long-term debt$0.00$20K$570K$1.22M$110K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$190K$200K$700K$1.43M$110K
Capital lease obligations$30K$60K$810K$1.7M$200K
Total liabilities$1.72M$1.73M$3.38M$5.6M$3.7M
Common stock$30K$30K$0.00$0.00$0.00
Retained earnings-$-14.19M-$-7.96M-$-7.27M$4.12M$7.18M
Accumulated other comprehensive income (loss)-$-1.69M-$-290K$140K$800K$2.4M
Total equity$22.6M$24.2M$21M$33M$32.6M
Total investments$7.06M$6.33M$7.21M$1.78M$2.44M
Total debt$30K$60K$810K$1.7M$200K
Net debt-$-8.07M-$-7.78M-$-6.74M-$-9.82M-$-13.71M
Cash flow statement
20252024202320222021
Net income-$-6.31M-$-270K-$-11.31M-$-2.82M$240K
Depreciation and amortization$320K$430K$920K$730K$700K
Stock-based compensation$0.00$110K$140K$160K$210K
Change in working capital$1.82M-$-2M$2.69M$170K$1.53M
Accounts receivable$1.17M-$-2.32M$2.79M$1.08M-$-100K
Inventory$600K-$-10K-$-410K-$-190K$0.00
Accounts payable-$-30K-$-130K$550K$100K-$-380K
Net cash provided by operating activities$850K-$-1.47M$50K-$-660K$2.86M
Investments in property, plant and equipment-$-150K-$-3.05M-$-840K-$-1.86M-$-1.8M
Acquisitions, net$0.00$0.00$0.00-$-3.05M-$-710K
Net cash used for investing activities-$-830K-$-1.81M-$-3.75M-$-3.35M-$-4.02M
Common stock issued$0.00$3.84M$0.00$1.85M$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$0.00$3.84M$0.00$1.85M$0.00
Net change in cash$260K$290K-$-3.97M-$-2.39M-$-1.16M
Cash at end of period$8.1M$7.84M$7.55M$11.5M$13.9M
Operating cash flow$850K-$-1.47M$50K-$-660K$2.86M
Capital expenditure-$-150K-$-3.05M-$-840K-$-1.86M-$-1.8M
Free cash flow$690K-$-4.52M-$-790K-$-2.52M$1.06M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Zhongchao Inc.

        Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

        CEO
        Weiguang Yang
        Employees
        33
        Beta
        -0.01

        Explore

        Frequently asked questions

        What is the intrinsic value of Zhongchao Inc. (ZCMD)?

        InvestorsCraft does not currently publish an intrinsic value for ZCMD. How the IC value is calculated.

        Is ZCMD undervalued?

        InvestorsCraft does not publish an undervaluation signal for ZCMD at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.